Literature DB >> 21342072

Treatment of infection caused by Borrelia burgdorferi sensu lato.

Gary P Wormser1, Susan O'Connell.   

Abstract

Borrelia burgdorferi sensu lato (Bbsl) infections, which are transmitted by Ixodes ticks, cause a wide variety of clinical manifestations and are of public health importance in parts of North America, Europe and Asia. A literature review of pertinent articles published up untill July 6th 2010 was performed on the use of antimicrobials in the treatment and prevention of Bbsl infections. The clinical outcome with 10-28 days of antibiotic treatment is generally excellent, but in view of the experience with other infections, future studies might address whether the duration of antibiotic therapy could be shortened.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342072     DOI: 10.1586/eri.10.174

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  8 in total

1.  Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.

Authors:  Charles S Pavia; Gary P Wormser
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  [Lyme borreliosis].

Authors:  P Herzer; V Fingerle; H-W Pfister; A Krause
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

3.  Antiscience and ethical concerns associated with advocacy of Lyme disease.

Authors:  Paul G Auwaerter; Johan S Bakken; Raymond J Dattwyler; J Stephen Dumler; John J Halperin; Edward McSweegan; Robert B Nadelman; Susan O'Connell; Eugene D Shapiro; Sunil K Sood; Allen C Steere; Arthur Weinstein; Gary P Wormser
Journal:  Lancet Infect Dis       Date:  2011-09       Impact factor: 25.071

4.  Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

Authors:  Adriana Marques; Sam R Telford; Siu-Ping Turk; Erin Chung; Carla Williams; Kenneth Dardick; Peter J Krause; Christina Brandeburg; Christopher D Crowder; Heather E Carolan; Mark W Eshoo; Pamela A Shaw; Linden T Hu
Journal:  Clin Infect Dis       Date:  2014-02-11       Impact factor: 9.079

5.  Identification of membrane associated drug targets in Borrelia burgdorferi ZS7- subtractive genomics approach.

Authors:  Shivkumar Madagi; Vijayakumari Mali Patil; Saremy Sadegh; Abhishek Kumar Singh; Bhavana Garwal; Atreyi Banerjee; Usha Talambedu; Biplab Bhattacharjee
Journal:  Bioinformation       Date:  2011-07-19

6.  The pain of "chronic Lyme disease": moving the discourse in a different direction.

Authors:  Phillip J Baker
Journal:  FASEB J       Date:  2011-09-07       Impact factor: 5.191

7.  ACVIM consensus update on Lyme borreliosis in dogs and cats.

Authors:  Meryl P Littman; Bernhard Gerber; Richard E Goldstein; Mary Anna Labato; Michael R Lappin; George E Moore
Journal:  J Vet Intern Med       Date:  2018-03-22       Impact factor: 3.333

8.  Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy.

Authors:  M S Dryden; K Saeed; S Ogborn; P Swales
Journal:  Epidemiol Infect       Date:  2014-05-09       Impact factor: 4.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.